Feedback / Questions
sabirnetug IV (ACU193 IV) - Acumen Pharma
https://www.globenewswire.com/news-release/2024/10/23/2967694/0/en/Acumen-Pharmaceuticals-to-Deliver-Late-Breaking-Presentation-at-17th-Annual-Clinical-Trials-on-Alzheimer-s-Disease-CTAD-Conference.html
Oct 23, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next